Pricing Log in Create free account

Inogen, Inc (INGN) vs Neuronetics, Inc. (STIM)

Inogen, Inc and Neuronetics, Inc. are both Medical Devices companies. Inogen, Inc and Neuronetics, Inc. are of similar size ($185.2M and $179.7M). Neuronetics, Inc. grew revenue faster over the last twelve months: 23.0% against 3.15%. Inogen, Inc has the higher net margin (−6.94% vs −14.5%) and the lower return on invested capital (−28.4% vs −16.7%). Across the 18 metrics below, Inogen, Inc leads on 12 and Neuronetics, Inc. on 6.

Valuation

Metric INGN STIM Medical Devices median
P/E n/m n/m 25.58
P/S 0.52 1.18 2.54
P/B 1.04 8.39 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 0.21 1.47 2.72
Earnings yield (13.33%) (13.52%) (12.82%)
Free cash flow yield (4.30%) (4.90%) (8.18%)

Profitability

Metric INGN STIM Medical Devices median
Gross margin 44.51% 50.68% 57.76%
Operating margin (8.71%) (9.39%) (15.07%)
Net margin (6.94%) (14.45%) (14.45%)
Free cash flow margin (2.22%) (5.18%) (3.88%)
Return on equity (13.14%) (85.85%) (10.35%)
Return on assets (8.23%) (16.64%) (17.26%)
Return on invested capital (28.35%) (16.72%) (5.27%)

Growth

Metric INGN STIM Medical Devices median
Revenue growth (TTM) 3.15% 23.01% 10.41%
EPS growth (last fiscal year) 43.42% 56.93% 28.17%
Revenue growth, 5-year CAGR 2.48% 24.81% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INGN STIM Medical Devices median
Debt to equity 0.00 2.76 0.04
Current ratio 2.74 2.01 2.74
Net debt to EBITDA 12.66 (1.12) 0.54

Dividend

Metric INGN STIM Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric INGN STIM Medical Devices median
Market cap 179.67m 185.16m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack